We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-19.92%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$788M
AUM Growth
-$156M
Cap. Flow
-$1.06B
Cap. Flow %
-134.35%
Top 10 Hldgs %
80.89%
Holding
183
New
45
Increased
18
Reduced
27
Closed
85

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.91M
2
VALE icon
Vale
VALE
+$5.95M
3
WRB icon
W.R. Berkley
WRB
+$5.25M
4
EQH icon
Equitable Holdings
EQH
+$4.37M
5
LRCX icon
Lam Research
LRCX
+$4.09M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$634M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$40.6M
3
UNH icon
UnitedHealth
UNH
+$35.1M
4
QCOM icon
Qualcomm
QCOM
+$35.1M
5
AMZN icon
Amazon
AMZN
+$34.8M

Sector Composition

Rank Sector Weight
1 Healthcare 72.44%
2 Financials 6.85%
3 Technology 5.83%
4 Materials 4.33%
5 Communication Services 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VER
176
DELISTED
VEREIT, Inc.
VER
-64,260
Closed -$2.43M
HR
177
DELISTED
Healthcare Realty Trust Incorporated
HR
-156,707
Closed -$4.64M

Similar funds

Crestline Management's Q1 2021 Portfolio in Review

As of Q1 2021, Crestline Management held 183 positions worth $788M, down 16% from $943M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Crestline Management withdrew a net $1.06B in Q1 2021, closing 85 positions and reducing 27 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 41% a quarter earlier, followed by Financials and Technology.

Against the trend, Crestline Management opened a new position in Vale worth $5.93M.

  • Crestline Management's largest Q1 2021 buy was Vale: 341,000 shares worth $5.93M.
  • Crestline Management added most to Alphabet (Google) Class A in Q1 2021, an estimated $6.91M increase.
  • Crestline Management's biggest Q1 2021 reduction was Denali Therapeutics, cutting an estimated $634M.
  • Crestline Management fully exited Berkshire Hathaway Class B in Q1 2021, selling an estimated $40.6M.
  • Crestline Management's ten largest holdings make up 81% of its $788M portfolio in Q1 2021.
  • Crestline Management opened 45 new positions and closed 85 in Q1 2021.
  • Crestline Management's portfolio value fell 16% quarter-over-quarter to $788M.

Based on Crestline Management's 13F filing for Q1 2021, filed 14 May 2021.